Dexcom appoints former Masimo exec as chief commercial officer
By HME News Staff
Updated 10:04 AM CDT, Thu March 27, 2025
SAN DIEGO – Dexcom has named Jon Coleman as chief commercial officer to oversee the company’s global commercial organization, including sales, marketing and customer experience. “Jon has demonstrated the ability to lead organizations through the complexities of global health care with consistently strong performance across a variety of sectors and channels,” said Kevin Sayer, chairman, president and CEO at Dexcom. “This broad experience across market segments and regions provides a great fit as we look to capitalize on Dexcom’s incredible growth opportunity.” Coleman joins Dexcom with more than 30 years of global commercial leadership experience across multiple health care segments and channels, including as an executive officer of Masimo Corp., where he held roles of increasing responsibility across his 15-year tenure. “Dexcom’s commitment to drive innovation in glucose biosensing and its unique long-term growth opportunity make the chief commercial officer role an incredible opportunity,” he said. “I am excited to lead this great team at a key point in the company’s history and execute on the company’s ambitious vision to empower greater health around the world.”
Comments